Literature DB >> 29750499

Alpha Synuclein Fibrils Contain Multiple Binding Sites for Small Molecules.

Chia-Ju Hsieh1, John J Ferrie2, Kuiying Xu1, Iljung Lee1, Thomas J A Graham1, Zhude Tu3, Jennifer Yu4, Dhruva Dhavale4, Paul Kotzbauer4, E James Petersson2, Robert H Mach1.   

Abstract

The fibrillary aggregation of the protein alpha synuclein (Asyn) is a hallmark of Parkinson's disease, and the identification of small molecule binding sites on fibrils is essential to the development of diagnostic imaging probes. A series of molecular modeling, photoaffinity labeling, mass spectrometry, and radioligand binding studies were conducted on Asyn fibrils. The results of these studies revealed the presence of three different binding sites within fibrillar Asyn capable of binding small molecules with moderate to high affinity. A knowledge of the amino acid residues in these binding sites will be important in the design of high affinity probes capable of imaging fibrillary species of Asyn.

Entities:  

Keywords:  Alpha synuclein; Lewy bodies; Lewy neurites; Parkinson’s disease

Mesh:

Substances:

Year:  2018        PMID: 29750499      PMCID: PMC6736640          DOI: 10.1021/acschemneuro.8b00177

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  11 in total

1.  Synthesis and characterization of high affinity fluorogenic α-synuclein probes.

Authors:  Zsofia Lengyel-Zhand; John J Ferrie; Bieneke Janssen; Chia-Ju Hsieh; Thomas Graham; Kui-Ying Xu; Conor M Haney; Virginia M-Y Lee; John Q Trojanowski; E James Petersson; Robert H Mach
Journal:  Chem Commun (Camb)       Date:  2020-03-24       Impact factor: 6.222

2.  Pharmacophore modeling and 3D-QSAR study for the design of novel α-synuclein aggregation inhibitors.

Authors:  Jixia Yang; Jiajing Hu; Gongzheng Zhang; Li Qin; Hongliang Wen; Yun Tang
Journal:  J Mol Model       Date:  2021-08-25       Impact factor: 1.810

3.  JM-20, a Benzodiazepine-Dihydropyridine Hybrid Molecule, Inhibits the Formation of Alpha-Synuclein-Aggregated Species.

Authors:  Cleonice Creusa Santos; Thyago R Cardim-Pires; Liana Shvachiy; Luis Arturo Fonseca-Fonseca; Patricia Muñoz; Áurea Maria A N Almeida; Ana Carla S Costa; Jéssica Teles-Souza; Estael Ochoa-Rodríguez; Maria de Fátima Dias Costa; Fernando L Palhano; Juan Segura-Aguilar; Deyse B Barbosa; Mayra R do Bomfim; Manoelito C Dos Santos Junior; Franco Henrique A Leite; Samuel Silva da Rocha Pita; Silvia Lima Costa; Yanier Núñez-Figueredo; Tiago Fleming Outeiro; Débora Foguel; Victor Diogenes Amaral Silva
Journal:  Neurotox Res       Date:  2022-08-23       Impact factor: 3.978

Review 4.  The role of neuroimaging in Parkinson's disease.

Authors:  Natasha S R Bidesi; Ida Vang Andersen; Albert D Windhorst; Vladimir Shalgunov; Matthias M Herth
Journal:  J Neurochem       Date:  2021-10-03       Impact factor: 5.546

5.  [11C]MODAG-001-towards a PET tracer targeting α-synuclein aggregates.

Authors:  Laura Kuebler; Sabrina Buss; Andrei Leonov; Sergey Ryazanov; Felix Schmidt; Andreas Maurer; Daniel Weckbecker; Anne M Landau; Thea P Lillethorup; Daniel Bleher; Ran Sing Saw; Bernd J Pichler; Christian Griesinger; Armin Giese; Kristina Herfert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-12-28       Impact factor: 9.236

6.  Dammarane triterpenes targeting α-synuclein: biological activity and evaluation of binding sites by molecular docking.

Authors:  Alberto Cornejo; Julio Caballero; Mario Simirgiotis; Vanessa Torres; Luisa Sánchez; Nicolás Díaz; Marcela Guimaraes; Marcos Hernández; Carlos Areche; Sergio Alfaro; Leonardo Caballero; Francisco Melo
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

7.  Identification of a nanomolar affinity α-synuclein fibril imaging probe by ultra-high throughput in silico screening.

Authors:  John J Ferrie; Zsofia Lengyel-Zhand; Bieneke Janssen; Marshall G Lougee; Sam Giannakoulias; Chia-Ju Hsieh; Vinayak Vishnu Pagar; Chi-Chang Weng; Hong Xu; Thomas J A Graham; Virginia M-Y Lee; Robert H Mach; E James Petersson
Journal:  Chem Sci       Date:  2020-09-10       Impact factor: 9.969

8.  Non-monotonic fibril surface occlusion by GFP tags from coarse-grained molecular simulations.

Authors:  Julian C Shillcock; Janna Hastings; Nathan Riguet; Hilal A Lashuel
Journal:  Comput Struct Biotechnol J       Date:  2021-12-15       Impact factor: 7.271

9.  Embelin and levodopa combination therapy for improved Parkinson's disease treatment.

Authors:  Vagdevi Hangarakatte Ramachandra; Senthilkumar Sivanesan; Anand Koppal; Shanmugam Anandakumar; Matthew D Howell; Ethirajan Sukumar; Rajagopalan Vijayaraghavan
Journal:  Transl Neurosci       Date:  2022-06-29       Impact factor: 1.264

Review 10.  Natural and Synthetic Derivatives of Hydroxycinnamic Acid Modulating the Pathological Transformation of Amyloidogenic Proteins.

Authors:  Vladimir I Muronetz; Kseniya Barinova; Sofia Kudryavtseva; Maria Medvedeva; Aleksandra Melnikova; Irina Sevostyanova; Pavel Semenyuk; Yulia Stroylova; Matej Sova
Journal:  Molecules       Date:  2020-10-12       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.